Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer
Abstract Background By the traditional definition of unintended weight loss, cachexia develops in ~80% of patients with pancreatic ductal adenocarcinoma (PDAC). Here, we measure the longitudinal body composition changes in patients with advanced PDAC undergoing 5‐fluorouracil, leucovorin, irinotecan...
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
Wiley
2018-08-01
|
| Серии: | Journal of Cachexia, Sarcopenia and Muscle |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/jcsm.12307 |